Activity Overview
This educational activity is an archive of the live conference held on July 11 – 12, 2026.
Target Audience
This educational activity is directed toward hematologists, medical oncologists, and fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
- Develop longitudinal treatment strategies that incorporate sequencing across lines of therapy, prior treatment exposure, and anticipated next-line options
Barbara Pro, MD
Professor of Medicine, Division of Hematology
and Oncology
Columbia University Vagelos College of
Physicians and Surgeons
Clinical Director, Lymphoma Program
Herbert Irving Comprehensive Cancer Center
NewYork-Presbyterian/Columbia University
Irving Medical Center
New York, NY
Brandon DaSilva, MD
Clinical Fellow
Columbia University Irving Medical Center
New York, NY
Lorenzo Falchi, MD
Assistant Attending Physician
Lymphoma Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
Assistant Professor of Medicine
Weill Cornell Medical College
New York, NY
Thomas Martin, MD
Clinical Professor of Medicine
Adult Leukemia and Bone Marrow
Transplantation Program
Associate Director, Myeloma Program, UCSF
Co-Leader, Cancer Immunology &
Immunotherapy Program
Helen Diller Family Comprehensive Cancer
Center
University of California, San Francisco
San Francisco, CA
Alain Mina, MD
Assistant Professor of Medicine
Section of Medical Oncology and
Hematology–Cellular Therapy and Stem Cell
Transplant
Yale School of Medicine
Yale Comprehensive Cancer Center
New Haven, CT
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
